Brain dopamine and serotonin differ in regulation and its consequences

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 29, 2012, Pages 11510-11515

  Hashemi, Parastoo ^a   Dankoski, Elyse C ^b   Lama, Rinchen ^a   Wood, Kevin M ^a   Takmakov, Pavel ^a   Wightman, R Mark ^a,b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Electrical stimulation; monoamine oxidase inhibitor; Selective serotonin reuptake inhibitor

Indexed keywords

5 HYDROXYTRYPTOPHAN; CARBON FIBER; CITALOPRAM; DOPAMINE; LEVODOPA; METITEPINE; PARGYLINE; RACLOPRIDE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG RESPONSE; MEDIAL FOREBRAIN BUNDLE; MICROELECTRODE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SEROTONIN BLOOD LEVEL; SEROTONINERGIC SYSTEM; SUBSTANTIA NIGRA PARS RETICULATA;

ANALYSIS OF VARIANCE; ANIMALS; CARBON; DOPAMINE; ELECTRIC STIMULATION; ELECTROCHEMICAL TECHNIQUES; MICROELECTRODES; MONOAMINE OXIDASE INHIBITORS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SUBSTANTIA NIGRA;

RATTUS;

EID: 84863892584     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1201547109     Document Type: Article

References (50)

1. Haber SN, Knutson B (2010) The reward circuit: Linking primate anatomy and human imaging. Neuropsychopharmacology 35:4-26.
2. Jacobs BL, Fornal CA (1999) Activity of serotonergic neurons in behaving animals. Neuropsychopharmacology 21(2, Suppl):9S-15S. (Pubitemid 29396465)
3. Daw ND, Kakade S, Dayan P (2002) Opponent interactions between serotonin and dopamine. Neural Netw 15:603-616. (Pubitemid 34951146)
4. Boureau YL, Dayan P (2011) Opponency revisited: competition and cooperation between dopamine and serotonin. Neuropsychopharmacology 36:74-97.
5. Millar J, Stamford JA, Kruk ZL, Wightman RM (1985) Electrochemical, pharmacological and electrophysiological evidence of rapid dopamine release and removal in the rat caudate nucleus following electrical stimulation of the median forebrain bundle. Eur J Pharmacol 109:341-348. (Pubitemid 15108982)
6. Gonon FG, Buda MJ (1985) Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatum. Neuroscience 14: 765-774. (Pubitemid 15112239)
7. Robinson DL, Hermans A, Seipel AT, Wightman RM (2008) Monitoring rapid chemical communication in the brain. Chem Rev 108:2554-2584.
8. Day JJ, Roitman MF, Wightman RM, Carelli RM (2007) Associative learning mediates dynamic shifts in dopamine signaling in the nucleus accumbens. Nat Neurosci 10: 1020-1028. (Pubitemid 47185195)
9. Owesson-White CA, Cheer JF, Beyene M, Carelli RM, Wightman RM (2008) Dynamic changes in accumbens dopamine correlate with learning during intracranial selfstimulation. Proc Natl Acad Sci USA 105:11957-11962.
10. Sombers LA, Beyene M, Carelli RM, Wightman RM (2009) Synaptic overflow of dopamine in the nucleus accumbens arises from neuronal activity in the ventral tegmental area. J Neurosci 29:1735-1742.
11. Jackson BP, Dietz SM, Wightman RM (1995) Fast-scan cyclic voltammetry of 5-hydroxytryptamine. Anal Chem 67:1115-1120.
12. Hashemi P, Dankoski EC, Petrovic J, Keithley RB, Wightman RM (2009) Voltammetric detection of 5-hydroxytryptamine release in the rat brain. Anal Chem 81:9462-9471.
13. Gerhardt GA, Oke AF, Nagy G, Moghaddam B, Adams RN (1984) Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res 290:390-395. (Pubitemid 14217008)
14. Hashemi P, Dankoski EC, Wood KM, Ambrose RE, Wightman RM (2011) In vivo electrochemical evidence for simultaneous 5-HT and histamine release in the rat substantia nigra pars reticulata following medial forebrain bundle stimulation. J Neurochem 118: 749-759.
15. Zachek MK, Takmakov P, Moody B, Wightman RM, McCarty GS (2009) Simultaneous decoupled detection of dopamine and oxygen using pyrolyzed carbon microarrays and fast-scan cyclic voltammetry. Anal Chem 81:6258-6265.
16. Garris PA, Wightman RM (1994) Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: An in vivo voltammetric study. J Neurosci 14:442-450. (Pubitemid 24022128)
17. Wiedemann DJ, Garris PA, Near JA, Wightman RM (1992) Effect of chronic haloperidol treatment on stimulated synaptic overflow of dopamine in the rat striatum. J Pharmacol Exp Ther 261:574-579.
18. Montague PR, et al. (2004) Dynamic gain control of dopamine delivery in freely moving animals. J Neurosci 24:1754-1759. (Pubitemid 38240973)
19. Owesson-White CA, et al. (2012) Sources contributing to the average extracellular concentration of dopamine in the nucleus accumbens. J Neurochem 121:252-262.
20. Garris PA, Wightman RM (1995) Regional differences in dopamine release, uptake, and diffusion measured by fast-scan cyclic voltammetry. Voltammetric Methods in Brain Systems, Neuromethods, eds Boulton A, Baker G, Adams RN (Humana, Totowa, NJ), pp 179-220.
21. Stamford JA, Kruk ZL, Millar J (1988) Stimulated limbic and striatal dopamine release measured by fast cyclic voltammetry: Anatomical, electrochemical and pharmacological characterisation. Brain Res 454:282-288.
22. Carlsson A, Davis JN, Kehr W, Lindqvist M, Atack CV (1972) Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn Schmiedebergs Arch Pharmacol 275:153-168.
23. Quinn GP, Shore PA, Brodie BB (1959) Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects. J Pharmacol Exp Ther 127:103-109.
24. Zheng G, Dwoskin LP, Crooks PA (2006) Vesicular monoamine transporter 2: Role as a novel target for drug development. AAPS J 8:E682-E692.
25. Monachon MA, Burkard WP, Jalfre M, Haefely W (1972) Blockade of central 5-hydroxytryptamine receptors by methiothepin. Naunyn Schmiedebergs Arch Pharmacol 274:192-197.
26. Köhler C, Hall H, Ogren SO, Gawell L (1985) Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Biochem Pharmacol 34:2251-2259. (Pubitemid 15061201)
27. Hyttel J (1982) Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 6: 277-295.
28. Andersen PH (1989) The dopamine inhibitor GBR 12909: Selectivity and molecular mechanism of action. Eur J Pharmacol 166:493-504.
29. Park J, Takmakov P, Wightman RM (2011) In vivo comparison of norepinephrine and dopamine release in rat brain by simultaneous measurements with fast-scan cyclic voltammetry. J Neurochem 119:932-944.
30. Palkovits M, Brownstein M, Saavedra JM (1974) Serotonin content of the brain stem nuclei in the rat. Brain Res 80:237-249.
31. Shields PJ, Eccleston D (1973) Evidence for the synthesis and storage of 5-hydroxytryptamine in two separate pools in the brain. J Neurochem 20:881-888.
32. Shore PA (1976) Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron. J Pharm Pharmacol 28:855-857.
33. Beaudet A, Descarries L (1981) The fine structure of central serotonin neurons. J Physiol (Paris) 77:193-203. (Pubitemid 11032669)
34. Grace AA, Bunney BS (1983) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-1. Identification and characterization. Neuroscience 10: 301-315. (Pubitemid 13019570)
35. Yavich L, MacDonald E (2000) Dopamine release from pharmacologically distinct storage pools in rat striatum following stimulation at frequency of neuronal bursting. Brain Res 870:73-79. (Pubitemid 30408405)
36. Van Bockstaele EJ, Pickel VM (1993) Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: Cellular substrates for interactions with catecholamine afferents. J Comp Neurol 334:603-617. (Pubitemid 23239020)
37. Henry JP, Sagné C, Bedet C, Gasnier B (1998) The vesicular monoamine transporter: from chromaffin granule to brain. Neurochem Int 32:227-246. (Pubitemid 28156443)
38. Torres GE, Amara SG (2007) Glutamate and monoamine transporters: New visions of form and function. Curr Opin Neurobiol 17:304-312. (Pubitemid 46880333)
39. Jain M, Sands F, Von Korff RW (1973) Monoamine oxidase activity measurements using radioactive substrates. Anal Biochem 52:542-554.
40. Budygin EA, Kilpatrick MR, Gainetdinov RR, Wightman RM (2000) Correlation between behavior and extracellular dopamine levels in rat striatum: Comparison of microdialysis and fast-scan cyclic voltammetry. Neurosci Lett 281:9-12. (Pubitemid 30109292)
41. Threlfell S, Greenfield SA, Cragg SJ (2010) 5-HT(1B) receptor regulation of serotonin (5-HT) release by endogenous 5-HT in the substantia nigra. Neuroscience 165: 212-220.
42. Chaput Y, Blier P, de Montigny C (1986) In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. J Neurosci 6:2796-2801. (Pubitemid 16026058)
43. Sesack SR, Aoki C, Pickel VM (1994) Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 14:88-106.
44. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152. (Pubitemid 29292403)
45. Daws LC, Gould GG, Teicher SD, Gerhardt GA, Frazer A (2000) 5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo. J Neurochem 75:2113-2122.
46. Daws LC, Gerhardt GA, Frazer A (1999) 5-HT1B antagonists modulate clearance of extracellular serotonin in rat hippocampus. Neurosci Lett 266:165-168. (Pubitemid 29249241)
47. Marley E, Wozniak KM (1984) Interactions of a non-selective monoamine oxidase inhibitor, phenelzine, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake. J Psychiatr Res 18:173-189. (Pubitemid 14081922)
48. Izumi T, et al. (2006) Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats. Eur J Pharmacol 532:258-264.
49. Mitchell PB (1997) Drug interactions of clinical significance with selective serotonin reuptake inhibitors. Drug Saf 17:390-406.
50. Lane R, Baldwin D (1997) Selective serotonin reuptake inhibitor-induced serotonin syndrome: Review. J Clin Psychopharmacol 17:208-221. (Pubitemid 27261777)